Daily Stock Analysis, CHEK, Check Cap Ltd, priceseries

Check Cap Ltd. Daily Stock Analysis
Stock Information
Open
2.15
Close
2.22
High
2.28
Low
2.15
Previous Close
2.15
Daily Price Gain
0.07
YTD High
4.20
YTD High Date
Jan 29, 2019
YTD Low
1.75
YTD Low Date
Feb 28, 2019
YTD Price Change
-0.05
YTD Gain
-2.20%
52 Week High
4.50
52 Week High Date
Sep 4, 2018
52 Week Low
1.62
52 Week Low Date
Dec 21, 2018
52 Week Price Change
-1.68
52 Week Gain
-43.08%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 11. 2018
11.12
Jan 16. 2018
12.16
2 Trading Days
9.34%
Link
LONG
Apr 17. 2018
4.97
Apr 18. 2018
5.33
1 Trading Days
7.34%
Link
LONG
Apr 23. 2018
7.26
Apr 26. 2018
8.66
3 Trading Days
19.32%
Link
LONG
Apr 27. 2018
9.02
May 3. 2018
10.12
4 Trading Days
12.25%
Link
LONG
Jan 2. 2019
2.27
Jan 14. 2019
2.65
8 Trading Days
16.86%
Link
LONG
Mar 7. 2019
2.05
Mar 27. 2019
2.80
14 Trading Days
36.69%
Link
Company Information
Stock Symbol
CHEK
Exchange
NasdaqCM
Company URL
http://www.check-cap.com
Company Phone
972-4-8303400
CEO
Bill Densel
Headquarters
-
Business Address
ABBA HUSHI AVENUE P.O. BOX 1271, ISFIYA, ISRAEL 30090
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001610590
About

Check-Cap Ltd. engages in developing gastrointestinal imaging devices. The company develops an ingestible imaging capsule that utilizes low-dose X-rays for Colorectal Cancer (CRC) screening. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.

Description

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of an ingestible imaging capsule that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit that is designed to track the capsule and record imaging and positioning data; and C-Scan View, a personal computer-based software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface. The company was founded in 2004 and is based in Isfiya, Israel.